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PURPOSE. Currently there are various heavy silicone oil (HSO) tamponade agents available for
treating inferior retinal diseases. Most of these HSO agents are either homogeneous liquids or
a mixture of two components. Variations in their emulsification rates in vivo have been
reported. In this study, we investigated their flow behaviors during eye-like movements.
METHODS. A model eye chamber filled with various HSO agents was driven to perform eye-like
movements. Five types of HSOs with different formulations together with 2 other tamponade
agents were tested. Movements of various HSOs inside the chamber were captured by video
recording and analyzed.
RESULTS. Oxane HD has a larger movement and higher velocity relative to the eye chamber
than the less viscous Densiron 68. The behavior of Densiron 68 is similar to that of
homogeneous HSO 1.07 and HSO 1.20. Both Oxane HD and 11% silica fluid show very
different behaviors compared to the other HSO agents. In addition, 11% silica fluid shows
behavior similar to that of F6H8, a low-viscosity tamponade agent.
CONCLUSIONS. The viscosity of HSO is not the sole parameter with which to determine the
behavior of HSO during eye movements. Various HSOs that are manufactured by mixing
different types of base SO and ‘‘heavy’’ additives show distinct flow behaviors. The solubility
and stability of the heavy additives in the base SO alter its flow when subjected to eye
movements, which may contribute to in vivo emulsification.
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Silicone oil (SO) has been used in vitreoretinal surgery for along time to repair complicated retinal detachment.1
Conventional SO has a specific gravity lower than water and
thus provides a good tamponade effect for breaks or holes in
the superior retina. There is also a group of SO that has a
specific gravity higher than water. That type of SO is designed
initially for treating proliferative vitreoretinopathy, which has a
propensity to affect the inferior part of the retina.2 Those types
are commonly called heavy silicone oil (HSO). The first
generation of HSO was made by substituting a few methylated
groups of conventional SO to fluorinated groups in order to
increase its specific gravity.3 However, that type of fluorosili-
cone oil was found to be toxic to ocular tissues,4 and it
emulsified much more quickly than conventional SO.5 In the
early 2000s, the second generation HSO, consisting of a mixture
of viscous SO with a low-viscosity fluorinated additive, was
introduced.6 The fluorinated additive contributes to the
increase in specific gravity of the resultant mixture. Two
commonly used examples of this type of HSO are Densiron 68
(mixture of SO and perfluorohexyloctane [Fluoron GmbH, Ulm,
Germany])7 and Oxane HD (SO and a partially fluorinated
olefin, RMN-3 [Bausch & Lomb, Inc., Waterford, Ireland]).8
They are well tolerated in human eyes and offer a satisfactory
support for the inferior retina.9 However, the fluorinated
additives in HSO are associated with emulsification in vivo.10,11
Segregation of the two components of HSO was proposed.12
Very recently, another novel HSO was also introduced. This
HSO was made by mixing a low-viscosity SO liquid with nano-
scale silica particles.13 These nano-sized silica particles increase
the specific gravity of the resultant mixture.
In this study, we studied the flow of various HSOs with
different formulations during eye movements by using the
dynamic eye chamber model. We compared the HSOs made of
two-component mixtures with typical fluorosilicone oil. We
hypothesized that the flow properties of these mixed HSOs are
different from the typical silicone oil.
MATERIALS AND METHODS
There were five types of heavy silicone oil, including Densiron
68 (Fluoron), Oxane HD (Bausch & Lomb), fluorosilicone oil
1.07 and 1.20 (Alamedics GmbH & Co. KG, Dornstadt,
Germany), and 11% silica solution. This study also included
the use of perfluorohexyloctane (F6H8; Fluoron) and sulfur
hexafluoride (SF6; Arcadophta, Toulouse, France), which are
short-term liquid and gas tamponades respectively. Physical
properties and compositions of these agents are listed in the
Table.
Study of the Motion of HSO in an Eye Model
Chamber
We used a study design and method similar to that published
recently.14 The eye chamber was made of poly(methylmetha-
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crylate) with a volume of approximately 6.3 mL. We estimated
the volume of an eyeball by assuming that a human eyeball is a
sphere with an axial length of 2.4 cm. Therefore, the volume of
the eyeball would be approximately 7.2 mL. Published figures
from magnetic resonance imaging studies in human gave the
volume of the eyeball and vitreous cavity as 6.013 6 0.449 mL
and 5.482 6 0.440 mL, respectively.15 We chose 6.3 mL as a
compromise. The inner surface of the chamber was coated
with protein to achieve a hydrophilic surface property.16 This
coating is essential because it prevents adhesion of the SO onto
the inner surface of the eye chamber and allows free
movement of the SO inside the chamber during rotation of
the chamber.
The eye model chambers were filled with 5 mL of each
testing agent containing trypan blue-colored phosphate-buff-
ered saline to avoid influx of air into the chamber. Eye
chambers were then mounted onto the mechanical platform
and subjected to preset large-amplitude eye-like movements
(amplitude, 908; angular velocity, 3608/s; duration, 300 ms)
repetitively.
Movements of the HSO contained within the eye chamber
during motion were recorded at a speed of 30 frames per
second. We drew a chord for each HSO bubble in each frame
and measured the gradient of these chords by using ImageJ
software (US National Institutes of Health, Bethesda, MD, USA).
The gradient was then converted to a value in terms of degrees.
This value reflected the corresponding angular displacement of
the HSO bubble in each photo frame. Angular velocity of the
HSO bubble could then be calculated by the change of angular
displacement within a certain time interval. The relative
velocity between the wall of the model eye chamber and the
HSO was also calculated by subtracting the velocity of the eye
chamber from the velocity of HSO.
Statistical Method
The unpaired t-tests were performed using Prism version 5
software (Graphpad, Chicago, IL, USA). P values of <0.05 were
considered statistically significant. Sample size was n¼ 8 for all
groups. All values in the graphs are means 6 standard
deviations (SD).
RESULTS
During rotation, Densiron 68 has the greatest angular
displacement (Figs. 1a, 1b). The angular displacement of
Oxane HD is between HSO 1.07 and HSO 1.20. The 11% silica
fluid has the smallest displacement among all the HSO groups.
F6H8 and SF6 had minimum displacement compared with
those of the other HSO agents. Similarly, Densiron 68 had the
highest angular velocity profile. Oxane HD had a lower angular
velocity profile than Densiron 68. Its behavior is similar to
those of HSO 1.07 and HSO 1.20. The 11% silica fluid has the
lowest velocity profile among all the HSO groups, and it is only
slightly higher than that of F6H8 and SF6 (Fig. 2a).
The angular velocity of HSO relative to the eye chamber
indicates the relative motion between the HSO agents and the
eye chamber during motion. Our data showed that Densiron
68 has the lowest angular velocity relative to the eye chamber
among the agents (Fig. 2b). There is not much to separate
Oxane HD from HSO 1.07 and HSO 1.20. The 11% silica fluid
has a very high angular velocity relative to the eye chamber,
which is also very similar to F6H8 and SF6.
The time required for the agents to come to rest inside the
chamber after the chamber stopped also varied. After the
chamber stopped (at time > 0.3 seconds), SF6 and F6H8 were
the earliest agents to come to rest (Fig. 3). The time needed for
Densiron 68 to come to rest was similar to those required for
HSO 1.07 and HSO 1.20. Both Oxane HD and 11% silica fluid
needed a significantly longer time than Densiron 68 to come to
rest.
DISCUSSION
‘‘Heavy’’ additives such as semifluorinated alkanes and alkenes
are commonly used in the formulation of HSO such as
Densiron 687 (SO and perfluorohexyloctane, F6H8) and Oxane
HD8 (SO and partially fluorinated olefin, RMN3). Densiron 68
and HSO 1.07 and HSO 1.20 show a similar fluidic behavior as
conventional SO in a previous study.14 On the other hand,
Oxane HD shows a quite different flow behavior. Oxane HD
needs a significantly longer time after the chamber stopped to
reach maximum displacement than Densiron 68 and HSO 1.07
and HSO 1.20 (Fig. 3). Oxane HD has a smaller maximum
angular displacement (Fig. 1b) and a higher relative velocity
(Fig. 2b) than Densiron 68, given that Oxane HD has a shear
viscosity (3800 millipascal seconds [mPa  s]) that is much
higher than that of Densiron 68 (1400 mPa  s). This finding
seemed to contradict the result in our previous study14 that
showed that SO with a higher shear viscosity tended to have a
smaller relative angular displacement and lower angular
velocity relative to the chamber wall during the chamber
rotation. In the previous study, all oils tested were polydime-
thylsiloxane (PDMS). No mixtures or solutions of two or more
different substances were tested. In the current study,
Densiron 68 returned to its original position soon after the
chamber stopped (Supplementary Video S1). This flow was
similar to those of the homogeneous PDMS-based SO14 and
fluorosilicone oil (HSO 1.07 and HSO 1.20). However, Oxane
HD needs a much longer time to return to its initial position
after reaching the maximum position of displacement
(Supplementary Video S2). This behavior is different to other
HSO agents such as Densiron 68, HSO 1.07, and HSO 1.20.




258C, mPa  s
Specific Gravity,
g/cm3 Composition
Densiron 68 1400 1.08 69.5% SO 5000 þ 30.5% F6H8
Oxane HD 3800 1.02 80.1% 5700 mPa  s SO þ 11.9%
RMN-3 (a partly fluorinated olefin)
11% silica fluid 2000 1.11 11% silica (Aerosil R972 Pharma silica)
þ 89% 22.5 mPa  s SO (556 cosmetic grade fluid)
HSO 1.07 Not provided by the manufacturer 1.07 Homogeneous fluorosilicone oil
HSO 1.20 Not provided by the manufacturer 1.20 Homogeneous fluorosilicone oil
F6H8 3.44 1.35 Perfluorohexyloctane
SF6 0.142 0.006265 Sulfur hexafluoride
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Differences in flow behaviors between Densiron 68 and Oxane
HD suggested that the effects of the heavy additives on the
fluidic properties of the base fluid should also be taken into
account in the design of HSOs. Previously, it was demonstrated
that RMN-3 in Oxane HD was not distributed homogenously
within SO, by using in vivo and in vitro nuclear magnetic
resonance imaging.17 Differences in the flow behaviors
between Densiron 68 and Oxane HD may be due to differences
in solubility and extent of segregation of the heavy additives in
the base SO fluid correspondingly.12 The heavy additive in
Oxane HD, RMN-3, may not dissolve in SO as well as F6H8 does
in Densiron 68, which alters the flow of the resultant mixture
subjected to eye movements. The flow behavior of Oxane HD
inside the eye chamber model might therefore be a combina-
tion of 1 of 2 distinctive flows. In addition to the latency of
stopped motion after the eye-like motion, both the relative
motion and the relative velocity increase in the case of Oxane
HD compared with Densiron 68. The increase in relative
velocity will lead to the increase in shear rate acting on the SO-
aqueous and SO-eye wall interfaces inside the eye cavity during
eye movements. As shear force is the product of shear rate and
viscosity, the increase in shear rate would lead to a higher shear
force acting on the SO. This results in a higher propensity of SO
to emulsify.14 In current clinical practice, most surgeons
believe that Densiron 68 is more emulsification resistant than
Oxane HD,12 based on their experience. This clinical
observation might be related to such a different flow behavior
between the two compounds.
The base fluid among all commercially available HSOs
varies, but most of the choices are SO with high viscosity. For
example, the base fluids of Densiron 68 and Oxane HD are
5000 mPa  s SO and 5700 mPa  s SO, respectively. The heavy
additives of these two HSOs are of low viscosity. Clinical
studies have shown the early emulsification of these
HSOs.12,18,19 The heavy additives are not viscous in nature,
and therefore they are suspected of causing the early
emulsification. The 11% silica fluid has a different design
than either Desiron 68 or Oxane HD. The viscosity of its base
fluid is very low, only 22.5 mPa  s. The dissolved silica
particles significantly increase the resultant viscosity to 2000
mPa  s. The resultant mixture has a greater tamponade
efficiency than Densiron 68 and Oxane HD.20 However, 11%
silica fluid shows a different flow behavior than the other
HSO candidates. The 11% silica fluid does not flow like either
Densiron 68 or Oxane HD and other viscous tamponade
agents. Instead, the flow of 11% silica fluid is similar to that of
the fluidic agent F6H8, with ripple-like flowing behavior
observed during the movement (Supplementary Videos S3,
S4). It also takes a longer time to reset to its initial position
after the eye chamber stops moving. This phenomenon may
also be due to a certain degree of segregation of the two
components in 11% silica fluid. The base fluid of 11% silica
fluid, 556 cosmetic grade fluid, is a polyphenylmethylsiloxane
with low viscosity and specific gravity. The additive Aerosil
R972 Pharma silica (Evonik, Essen, Germany) increases both
the viscosity and specific gravity. If the two components
segregate, the upper layer of 11% silica fluid in the chamber
would be the less viscous base fluid, and the lower part would
be more viscous, containing the silica. Under conditions of
the eye-like motion, the lower viscous layer moves much
FIGURE 1. (a) Angular position of various agents inside the eye model chamber at the start and end of the motion of the eye chamber. Images tagged
with number 1 indicate start of the motion of the chamber, and those tagged with number 10 indicate the end of the motion of the chamber. (b)
Angular displacement versus time of the eye chamber and different HSOs during 908 motion. The pink region indicates the period in which the
chamber accelerates; brown region indicates the period in which the chamber rotates at a constant velocity; blue region indicates the period in
which the chamber decelerates.
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faster than the less viscous upper layer due to differences in
diffusion of momentum between the two layers. Therefore,
ripples are observed in 11% silica fluid inside the chamber
during the rotation of the chamber. This ripple-like behavior
is similar to the flow of F6H8, which has a viscosity of only 3.4
mPa  s. Our results show that 11% silica fluid has a higher
motion and velocity in the eye chamber relative to those of
Densiron 68 and Oxane HD. This might cause an increase in
shear force between the 11% silica fluid phase and the water
phase. This may trigger an earlier and more severe emulsifi-
cation. On the other hand, the elasticity property of the
resultant 11% silica fluid may hinder the emulsification.
Because 11% silica fluid has not been involved in a clinical
trial, its emulsification resistance in vivo remains unknown.
FIGURE 2. (a) Angular velocity profiles of the eye chamber and different HSOs and agents during 908 motion. (b) Angular velocity profiles of the eye
chamber and different HSOs and agents relative to the chamber during 908 motion. The pink region indicates the period in which the chamber
accelerates; brown region indicates the period in which the chamber rotates at constant velocity; blue region indicates the period in which the
chamber decelerates.
FIGURE 3. Angular velocity profiles of different HSOs and agents relative to the chamber during and after the motion of the chamber. The brown
region indicates the period after the chamber stops.
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There is a limitation in this study because the chamber was
underfilled with tamponade agent. We chose to fill the model
chamber to approximately 80% (5 of 6.3 mL). We appreciate
that clinically, a degree of underfill could occur as a result of
incomplete vitrectomy and gel compression by gas or
silicone.21 Nevertheless, a fill of 80% is not so realistic.
Clinically, a much more complete fill is achieved especially
when SO is injected after air exchange.22 From the point of the
experiment, filling beyond 80% led to difficulty. The shape of
silicone inside the chamber was rounded, because it was
hydrophobic. In the past, we have showed that when silicone
filled a near-spherical cavity like the eyeball, the relationship
between volume (percentage fill) and linear dimension of the
bubble (height) was exponential.16 When the fill was much
more than 80%, the tamponade bubble ‘‘height’’ would be
nearly the same length as the diameter of the chamber. In other
words, it would be like visualizing a circle inside a circle. It was
difficult to accurately measure the meniscus and the position
of the bubble (relative to the chamber) using photographic
means. In a recent publication, we showed that the relative
movement and speed depended on a number of factors such as
the presence of an indent, viscosity of SO, and extent of SO fill.
Of these factors, the extent of SO fill was the least important.23
Crucially, for this study, the method aimed at comparing like
with like. All tamponade agents used were 5 mL in volume
(approximately 80%). We therefore believe these results are
valid.
CONCLUSIONS
In this study, we showed that the viscosity of HSO is not the
sole parameter with which to determine the behavior of HSO
during eye movements. Densiron 68 has a flow behavior
similar to that of the conventional SO as well as the
homogenous fluorosilicone oil. Both Oxane HD and 11% silica
fluid show flow patterns of a combined 1 of 2 distinctive flows.
This could be explained by the segregation of the additives and
the base oil. The solubility and the stability of the additives in
the base SO alter its flow when subjected to eye movements,
which may contribute to the emulsification in vivo.
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